RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+30.53%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.67B
AUM Growth
+$1.67B
(+20%)
Cap. Flow
-$28.6M
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
68.77%
Holding
48
New
8
Increased
25
Reduced
10
Closed
2
Top Buys
| 1 |
ProQR Therapeutics
PRQR
|
$72.4M |
| 2 |
Establishment Labs
ESTA
|
$18.1M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
$17.9M |
| 4 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$17.4M |
| 5 |
ResMed
RMD
|
$17M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$107M |
| 2 |
Regenxbio
RGNX
|
$46.8M |
| 3 |
PTC Therapeutics
PTCT
|
$37.5M |
| 4 |
Solid Biosciences
SLDB
|
$19.5M |
| 5 |
Arrowhead Research
ARWR
|
$13.3M |
Sector Composition
| 1 | Healthcare | 92.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
uniQure
QURE
$954M
| $15.6M | 0.93% |
428,980
+19,610
| +5% | +$714K |
|
|
27
Solid Biosciences
SLDB
$448M
| $12.4M | 0.74% |
17,488
-27,563
| -61% | -$19.5M |
|
28
Pacific Biosciences
PACB
$378M
| $12.1M | 0.72% |
+2,237,607
| New | +$12.1M |
|
29
CareDx
CDNA
$678M
| $10.3M | 0.62% |
357,766
-406,766
| -53% | -$11.7M |
|
30
Q32 Bio
QTTB
$20.9M
| $9.94M | 0.6% |
24,162
+11,582
| +92% | +$4.77M |
|
31
Viking Therapeutics
VKTX
$3.02B
| $8.71M | 0.52% |
+500,000
| New | +$8.71M |
|
|
VIVE
32
DELISTED
VIVEVE MED INC
VIVE
| $8.44M | 0.51% |
3,147
+286
| +10% | +$767K |
|
33
electroCore
ECOR
$38.8M
| $7.2M | 0.43% |
34,312
+612
| +2% | +$128K |
|
|
ODT
34
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $5.62M | 0.34% |
289,608
+13,240
| +5% | +$257K |
|
|
NVTR
35
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $5.52M | 0.33% |
251,329
-131,701
| -34% | -$2.89M |
|
36
Novavax
NVAX
$1.2B
| $5.21M | 0.31% |
138,551
+6,334
| +5% | +$238K |
|
37
Neuronetics
STIM
$216M
| $5.05M | 0.3% |
157,487
-32,513
| -17% | -$1.04M |
|
|
KA
38
DELISTED
Kineta, Inc. Common Stock
KA
| $2.72M | 0.16% |
8,065
+369
| +5% | +$124K |
|
39
argenx
ARGX
$44.2B
| $2.04M | 0.12% |
26,853
+1,294
| +5% | +$98.2K |
|
40
Catheter Precision
VTAK
$3.12M
| – | – |
0
| – | – |
|
41
Marker Therapeutics
MRKR
$11.2M
| $1.9M | 0.11% |
20,972
+972
| +5% | +$88K |
|
42
Eledon Pharmaceuticals
ELDN
$155M
| $1.48M | 0.09% |
17,570
+803
| +5% | +$67.5K |
|
43
Adverum Biotechnologies
ADVM
$68.2M
| $1.12M | 0.07% |
18,482
+845
| +5% | +$51.1K |
|
|
BLCM
44
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $970K | 0.06% |
15,749
+720
| +5% | +$44.3K |
|
|
MOTS
45
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $303K | 0.02% |
198
| – | – |
|
|
PTE
46
DELISTED
PolarityTE, Inc. Common Stock
PTE
| – | – |
-17,067
| Closed | -$10M |
|